Rezolute, Inc.
NASDAQ:RZLTBiotechnology
Healthcare
$4.25 +6.16%
+$0.30 today
- Market cap
- $411.10M
- Beta
- 0.65
- P/E (TTM)
- -6.5
- EPS (TTM)
- -$0.78
52W Low $1.07High $11.46
Volume 2.93M
Average 2.03M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$79.89M
FY 2025 · Annual
Net Income
-$74.41M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 13K | 0 | 0 | 0 | 0 |
| Gross Profit | (13K) | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 14.99M | 32.49M | 43.81M | 55.74M | 61.53M |
| Selling, General & Admin | 7.91M | 9.36M | 12.18M | 14.68M | 18.37M |
| Operating Expenses | 22.88M | 41.84M | 55.99M | 70.42M | 79.89M |
| Depreciation & Amortization | 13K | 13K | 30K | 36K | 31K |
| EBITDA | (20.51M) | (39.24M) | (51.76M) | (68.42M) | (74.38M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (22.89M) | (41.84M) | (55.99M) | (70.42M) | (79.89M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 63K | 80K | 4.21M | 4.87M | 5.48M |
| Interest Expense | 375K | 1.81M | 0 | 0 | 0 |
| Other Income / Expenses | 1.99M | 783K | 4.2M | 1.96M | 5.48M |
| Income Before Tax | (20.9M) | (41.06M) | (51.79M) | (68.46M) | (74.41M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (20.9M) | (41.06M) | (51.79M) | (68.46M) | (74.41M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (2.72) | (2.26) | (1.01) | (1.33) | (0.98) |
| EPS (Diluted) | (2.72) | (2.32) | (1.01) | (1.33) | (0.98) |
| 7.67M | 18.2M | 51.19M | 51.47M | 76M | |
| 7.67M | 19.49M | 51.19M | 51.47M | 76M |
RZLT Earnings Waterfall · TTM
NASDAQ:RZLT · Revenue to Net Income
Key Ratios
EPS$-0.82
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-6.3
P/S Ratio0.0
Analysis
$0 of revenue converted into -$81.5M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.82, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| FWP | FWP filing | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 424B5 | 424B5 filing | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 13, 2026 |
How much revenue does RZLT generate?
Rezolute, Inc. (RZLT) reported $0.00 of revenue in fiscal 2025.
Is RZLT profitable?
Rezolute, Inc. (RZLT) reported -$74.41M of net income.
Continue the stock analysis
Jump to another research area for this company.